• The Mayo Clinic Campus in Florida, based in Jacksonville, has agreed to a research agreement with SK Biopharmaceuticals of Seoul, South Korea, to develop new treatments for amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. Leonard Petrucelli, chair of the Department of Neuroscience Research at Mayo Clinic in Florida, is leading Mayo’s effort.
